This section examines single-domain VHH antibodies, from their compact structure to their practical uses. Articles address production methods, advantages, and the role these antibodies play in various contexts.
The alpaca advantage: VHH discovery powered by unique immune repertoires. See how Biointron leverages alpaca libraries for robust nanobody identification.
VHH combine small size with big performance—excellent stability, deep tissue access, and easy formatting—making them powerful tools for research and therapy.
You can also contact us on the Scientist and Science Exchange marketplaces.
Our website uses cookies to improve your experience. Read our Privacy Policy to find out more.
